首页> 外文期刊>The Lancet >Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan.
【24h】

Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan.

机译:参与管理计划后对花生和坚果过敏患者的长期前瞻性观察研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Peanut and nut allergy is common and the most frequent cause of severe or fatal reactions to foods. Current advice is poor--doctors give an epinephrine injector to patients, without training or advice on nut avoidance--so that further reactions are common and deaths occur. We devised and assessed a management programme providing advice on nut avoidance and emergency medication. METHODS: Unselected referrals with confirmed peanut or tree-nut allergy were recruited. Severity of nut allergy was graded 1-5 and emergency medication allocated accordingly: oral antihistamine with or without inhaled or injected epinephrine. Patients, parents, and school staff received verbal and written advice on nut avoidance as well as training in recognition and self-treatment of reactions, with a written treatment plan. At follow-up (more than 13610 patient months) retraining was given and details of further reactions obtained. FINDINGS: 88 (15%) of 567 patients had a follow-up reaction of reduced severity. 62 of 88 were mild (grades 1-3, mainly cutaneous) and 49 patients used oral antihistamine, six inhaled adrenaline, and ten took no treatment. 12 of 12 patients with a moderate follow-up reaction improved after inhaled epinephrine. Only three (0.5%) of 567 patients, aged 27-40 years, had a severe follow-up reaction (involving dyspnoea) compared with 12% initially. Only one of 567 changed from a mild index reaction to a severe follow-up reaction. Patients with a moderate/severe (grade 4-5) reaction were older (median 18 years vs 9 years; p=0.03) and nine of 26 received injected epinephrine which was always effective. 85% of patients had no further reactions. Severity was related to the amount of nut eaten. INTERPRETATION: Self-treatment was effective (inhaled epinephrine for early laryngeal oedema and an epinephrine injector for severe reactions) but provision of this treatment, including who should carry epinephrine, required assessment of allergy severity. Our management plan was effective, and our results indicate that patients should be referred to specialist allergy centres for advice on nut avoidance.
机译:背景:花生和坚果过敏是常见的食物,是引起食物严重或致命反应的最常见原因。目前的建议很差-医生给患者提供肾上腺素注射剂,而没有有关避免坚果的培训或建议-因此进一步的反应很普遍并且会导致死亡。我们设计并评估了一项管理计划,该计划提供有关避免坚果和紧急药物的建议。方法:招募未经证实的花生或树坚果过敏的推荐人。坚果过敏的严重程度为1-5级,并相应分配了紧急药物:口服或不吸入或注射肾上腺素的口服抗组胺药。患者,父母和学校工作人员会收到有关避免吃坚果的口头和书面建议,并接受有关反应识别和自我治疗的培训以及书面治疗计划。随访时(超过13610个患者月)进行了再培训,并获得了进一步反应的详细信息。结果:567名患者中有88名(15%)进行了严重程度降低的随访反应。 88例中有62例为轻度(1-3级,主要是皮肤),49例患者口服抗组胺药,6例吸入肾上腺素,10例未接受治疗。吸入肾上腺素后12例中度随访反应患者中有12例得到改善。在567名年龄在27至40岁之间的患者中,只有三名(0.5%)出现了严重的随访反应(涉及呼吸困难),而最初的这一比例为12%。 567名患者中只有一名从轻度指数反应变为严重的随访反应。具有中度/重度(4-5级)反应的患者年龄较大(中位18岁vs 9岁; p = 0.03),并且26名患者中有9名接受了肾上腺素注射,该疗法一直有效。 85%的患者没有进一步的反应。严重程度与食用坚果的量有关。解释:自我治疗是有效的(吸入肾上腺素可治疗早期喉头水肿,而肾上腺素注射剂可治疗严重反应),但要提供这种治疗方法(包括谁应该携带肾上腺素),需要评估过敏的严重程度。我们的管理计划是有效的,我们的结果表明应将患者转至专业的过敏中心,寻求有关避免坚果的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号